Trial · NCT02778906
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 26
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of patients with an improvement of acute inflammation characterised as improvement of synovitis (synovialitis or tenosynovitis) or osteitis in the MRI of the dominant hand after 6 months of treatment with abatacept or placebo | 6 months | |
| Secondary | RAMRIS synovitis score in the dominant hand 12 and 18 months. | 6,12,18 months | |
| Secondary | Tenosynovitis score in the dominant hand. | 6,12,18 months | |
| Secondary | Proportion of patients with new or persistent arthralgia. | 6,12,18 months | |
| Secondary | Time to disappearance of arthralgia. | 6 months | |
| Secondary | Proportion of patients with clinical arthritis defined by joint swelling | 6,12,18 months | |
| Secondary | Proportion of patients with RA (ACR/EULAR 2010 criteria) | 6,12,18 months | |
| Secondary | Proportion of patients with radiological progress in HR-pQCT analysis comparing baseline image with end of study image. | 18 months | |
| Secondary | Tender Joint Count 68 | 3,6,9,12,15 and 18 months | |
| Secondary | Disease activity score (DAS) 28 | 3,6,9,12,15 and 18 months | |
| Secondary | Visual analogue scale (VAS) pain | 3,6,9,12,15 and 18 months | |
| Secondary | Duration of joint stiffness | 3,6,9,12,15 and 18 months | |
| Secondary | Health assessment Questionnaire (HAQ-DI) | 6,12 and 18 months | |
| Secondary | Rheumatoid Arthritis Impact of Disease (RAID) | 6,12 and 18 months | |
| Secondary | Short Form 36 (SF-36) | 6,12 and 18 months | |
| Secondary | Bone mineral density (BMD) | 18 months | |
| Secondary | Bone volume per tissue volume (BV/TV) | 18 months | |
| Secondary | Cortical width in the micro-CT of the distal radius | 18 months | |
| Secondary | Cortical porosity in the micro-CT of the distal radius | 18 months | |
| Secondary | RAMRIS erosion score in the dominant hand 12 and 18 months. | 6. 12. 18 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02778906/registered